All News

Smarter therapies, evolving frailty tools, and more inclusive trials are finally extending myeloma's survival gains to older adults.

A federal court blocked RFK Jr's vaccine agenda, freezing the ACIP shakeup and safeguarding child vaccine access as the legal fight over vaccines intensifies.

Subcutaneous mosunetuzumab simplifies the delivery of the bispecific therapy for patients with relapsed/refractory follicular lymphoma, says Zahra Mahmoudjafari, PharmD, MBA, BCOP.

Vaccine schedule shifts may widen gaps; learn how safety-net workflows and community education counter misinformation and boost uptake.

Long-term adherence to healthy behaviors reduces the risk of cardiovascular disease and type 2 diabetes, even among individuals taking antihypertensive medications.

The complete response letter marks the second time that reproxalap, a medication for use in dry eye disease, has been rejected by the FDA.

Study links PFAS and forever chemicals in children and teens to lower bone density in adolescents—especially girls—highlighting critical exposure windows.

Rising global temperatures are silently driving a sedentary crisis, and the world’s most vulnerable populations are paying the steepest price.

Severe COVID-19 was rare in patients with multiple sclerosis even when vaccine responses were impaired.

Secukinumab becomes the only IL-17A inhibitor approved for this population and the first new mechanism in the indication in nearly a decade.

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, supporting potential pediatric label expansion.

Vutrisiran kept a favorable safety profile in patients with transthyretin amyloidosis treated for up to 58 months, with AE rates comparable to placebo and no new safety concerns.

Legislation that passed the Senate will introduce reform in how pharmacy benefit managers are addressed by CMS starting in 2028.

Galleri trial data show liquid biopsy multicancer early detection tests may cut stage IV diagnoses, despite the missed primary end point.

Reproductive health conditions raise child desire but lower pregnancy intentions, spotlighting infertility gaps in women’s health and urging proactive counseling and coverage reform.

The website officially launched on February 5, introducing a key part of the Trump administration’s health care plan.

New studies link abortion bans to higher births and WIC demand and spotlight care-access gaps, cancer disparities, and value-based reforms shaping 2026.

The mental health burden of vitiligo closely resembles atopic dermatitis but differs significantly from psoriasis, a study suggests.

GPT-4o reliably scored alopecia areata severity from scalp images, showing strong concordance with experienced dermatology providers without prior AI training.

Deupirfenidone received orphan drug designation from the FDA and European Commission for idiopathic pulmonary fibrosis treatment.

The findings bolster the case for using Bruton tyrosine kinase inhibitors in the treatment of Richter syndrome.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Experts examine MFN pricing, the Great Healthcare Plan, ACA subsidies, PBM reform, and CMS talks in 2026.

Experts discussed how systemic changes need to be made to help improve preventive care access, which in turn can improve outcomes.

Lindsey Dawson, MA, speaks about how budget decisions regarding ADAPs in Florida could affect patients with HIV should these decisions be made permanent.